« Back to Record
Citation APA

Jeschke, J., O'Hagan, H. M., Zhang, W., Vatapalli, R., Calmon, M. F., Danilova, L., Nelkenbrecher, C., Van Neste, L., Bijsmans, I. I., van Engeland, M., Gabrielson, E., Schuebel, K. K., Winterpacht, A., Baylin, S. B. T. S., Herman, J. G., & Ahuja, N. (2013). Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clinical cancer research, 19(12), 3201-3211. doi:10.1158/1078-0432.CCR-12-3751


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265324

Jeschke, J., O'Hagan, H. M., Zhang, W., Vatapalli, R., Calmon, M. F., Danilova, L., Nelkenbrecher, C., Van Neste, L., Bijsmans, I. I., van Engeland, M., Gabrielson, E., Schuebel, K. K., Winterpacht, A., Baylin, S. B. T. S., Herman, J. G., & Ahuja, N. (2013). Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clinical cancer research, 19(12), 3201-3211. doi:10.1158/1078-0432.CCR-12-3751